304 related articles for article (PubMed ID: 37139365)
21. Exploring gut-lung axis crosstalk in SARS-CoV-2 infection: Insights from a hACE2 mouse model.
Zhang Y; Ma Y; Sun W; Zhou X; Wang R; Xie P; Dai L; Gao Y; Li J
J Med Virol; 2024 Jan; 96(1):e29336. PubMed ID: 38193530
[TBL] [Abstract][Full Text] [Related]
22. The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19?
Brooks EF; Bhatt AS
Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33593727
[TBL] [Abstract][Full Text] [Related]
23. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.
Wang M; Zhang Y; Li C; Chang W; Zhang L
Front Immunol; 2023; 14():1180336. PubMed ID: 37205106
[TBL] [Abstract][Full Text] [Related]
24. Gastrointestinal manifestations and SARS-CoV-2 infection.
Pizuorno A; Brim H; Ashktorab H
Curr Opin Pharmacol; 2021 Dec; 61():114-119. PubMed ID: 34688995
[TBL] [Abstract][Full Text] [Related]
25. Gastrointestinal symptoms, pathophysiology, and treatment in COVID-19.
Zhang J; Garrett S; Sun J
Genes Dis; 2021 Jul; 8(4):385-400. PubMed ID: 33521210
[TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis.
Cheung KS; Hung IFN; Chan PPY; Lung KC; Tso E; Liu R; Ng YY; Chu MY; Chung TWH; Tam AR; Yip CCY; Leung KH; Fung AY; Zhang RR; Lin Y; Cheng HM; Zhang AJX; To KKW; Chan KH; Yuen KY; Leung WK
Gastroenterology; 2020 Jul; 159(1):81-95. PubMed ID: 32251668
[TBL] [Abstract][Full Text] [Related]
27. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
28. COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?
Troisi J; Venutolo G; Pujolassos Tanyà M; Delli Carri M; Landolfi A; Fasano A
World J Gastroenterol; 2021 Apr; 27(14):1406-1418. PubMed ID: 33911464
[TBL] [Abstract][Full Text] [Related]
29. Autoimmunity and COVID-19 - The microbiotal connection.
Katz-Agranov N; Zandman-Goddard G
Autoimmun Rev; 2021 Aug; 20(8):102865. PubMed ID: 34118455
[TBL] [Abstract][Full Text] [Related]
30. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection.
Ahlawat S; Asha ; Sharma KK
Virus Res; 2020 Sep; 286():198103. PubMed ID: 32717345
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection.
Natarajan A; Zlitni S; Brooks EF; Vance SE; Dahlen A; Hedlin H; Park RM; Han A; Schmidtke DT; Verma R; Jacobson KB; Parsonnet J; Bonilla HF; Singh U; Pinsky BA; Andrews JR; Jagannathan P; Bhatt AS
Med; 2022 Jun; 3(6):371-387.e9. PubMed ID: 35434682
[TBL] [Abstract][Full Text] [Related]
32. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.
Zhang F; Wan Y; Zuo T; Yeoh YK; Liu Q; Zhang L; Zhan H; Lu W; Xu W; Lui GCY; Li AYL; Cheung CP; Wong CK; Chan PKS; Chan FKL; Ng SC
Gastroenterology; 2022 Feb; 162(2):548-561.e4. PubMed ID: 34687739
[TBL] [Abstract][Full Text] [Related]
33. Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection.
Li J; Jing Q; Li J; Hua M; Di L; Song C; Huang Y; Wang J; Chen C; Wu AR
Microbiome; 2023 Mar; 11(1):38. PubMed ID: 36869345
[TBL] [Abstract][Full Text] [Related]
34. Gut-lung axis and dysbiosis in COVID-19.
Aktas B; Aslim B
Turk J Biol; 2020; 44(3):265-272. PubMed ID: 32595361
[TBL] [Abstract][Full Text] [Related]
35. Intestinal permeability changes with bacterial translocation as key events modulating systemic host immune response to SARS-CoV-2: A working hypothesis.
Cardinale V; Capurso G; Ianiro G; Gasbarrini A; Arcidiacono PG; Alvaro D
Dig Liver Dis; 2020 Dec; 52(12):1383-1389. PubMed ID: 33023827
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal manifestations and nutritional therapy during COVID-19 pandemic: a practical guide for pediatricians.
Oba J; Carvalho WB; Silva CA; Delgado AF
Einstein (Sao Paulo); 2020; 18():eRW5774. PubMed ID: 32667418
[TBL] [Abstract][Full Text] [Related]
37. Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection.
Trottein F; Sokol H
Cell Rep; 2020 Jul; 32(3):107915. PubMed ID: 32649864
[TBL] [Abstract][Full Text] [Related]
38. Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms.
Mendes de Almeida V; Engel DF; Ricci MF; Cruz CS; Lopes ÍS; Alves DA; d' Auriol M; Magalhães J; Machado EC; Rocha VM; Carvalho TG; Lacerda LSB; Pimenta JC; Aganetti M; Zuccoli GS; Smith BJ; Carregari VC; da Silva Rosa E; Galvão I; Dantas Cassali G; Garcia CC; Teixeira MM; André LC; Ribeiro FM; Martins FS; Saia RS; Costa VV; Martins-de-Souza D; Hansbro PM; Marques JT; Aguiar ERGR; Vieira AT
Gut Microbes; 2023 Dec; 15(2):2249146. PubMed ID: 37668317
[TBL] [Abstract][Full Text] [Related]
39. Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity.
Chakraborty C; Sharma AR; Bhattacharya M; Dhama K; Lee SS
World J Gastroenterol; 2022 Jul; 28(25):2802-2822. PubMed ID: 35978881
[TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal microbiota: A predictor of COVID-19 severity?
Neag MA; Vulturar DM; Gherman D; Burlacu CC; Todea DA; Buzoianu AD
World J Gastroenterol; 2022 Dec; 28(45):6328-6344. PubMed ID: 36533107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
